Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Joining forces with GFE allows us to connect complementary areas of expertise within molecular diagnostics and blood ...